Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement

European Journal of Endocrinology

Volumn 137, Issue 2, 1997, Pages 132-137

  Skjaerbaek C ^a,b   Vahl, N ^b   Frystyk, J ^a   Hansen, T B ^c   Jorgensen J O L ^b   Hagen, C ^c   Christiansen, J S ^b   Orskov H ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; MALE; ONSET AGE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BODY MASS INDEX; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; REFERENCE VALUES; TIME FACTORS;

EID: 0030857832     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1370132     Document Type: Article

References (23)

1. Furlanetto RW, Underwood LE, Van Wyk JJ & D'Ercole AJ. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. Journal of Clinical Investigation 1977 60 648-657.
2. Bates AS, Evans AJ, Jones P & Clayton RN. Assessment of GH status in adults with GH deficiency using serum growth hormone, serum insulin-like growth factor-I and urinary growth hormone excretion. Clinical Endocrinology 1995 42 425-450.
3. Huffman DM, O'Sullivan AJ, Baxter RC & Ho KK. Diagnosis of growth-hormone deficiency in adults. Lancet 1994 343 1064-1068.
4. Baum HB, Biller BM, Katznelson L, Oppenheim DS, Clemmons DR, Cannistraro KB et al. Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men - a clinical research center study. Journal of Clinical Endocrinology and Metabolism 1996 81 84-92.
5. Jørgensen JOL, Flyvbjerg A, Lauritzen T, Alberti KG, Ørskov H & Christiansen JS. Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients. Journal of Clinical Endocrinology and Metabolism 1988 67 36-40.
6. Møller J, Jørgensen JOL, Lauersen T, Frystyk J, Næraa RW, Ørskov H et al. Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clinical Endocrinology 1993 39403-408.
7. de Boer H, Blok GJ & van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocrine Review 1995 16 63-86.
8. Frystyk J, Skjærbæk C, Dinesen B & Ørskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Letters 1994 348 185-191.
9. Hansen TB, Vahl N, Jørgensen JOL, Christiansen JS & Hagen C. Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double-blind, randomized, placebo-controlled study. Clinical Endocrinology 1995 43 689-696.
10. Frystyk J, Dinesen B & Ørskov H. Non-competitive time-resolved immunofluorimetric assay for determination of human insulin-like growth factor I and II. Growth Regulation 1995 5 169-176.
11. Hasegawa Y, Hasegawa T, Takada M & Tsuchiya Y. Plasma free insulin-like growth factor I concentrations in growth hormone deficiency in children and adolescents. European Journal of Endocrinology 1996 134 184-189.
12. Frystyk J, Vestbo E, Skjærbæk C, Mogensen CE & Ørskov H. Free insulin-like growth factors in human obesity. Metabolism 1995 44 (suppl 4) 37-44.
13. Hilding A, Brismar K, Degerblad M, Thoren M & Hall K. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared with that in healthy subjects. Journal of Clinical Endocrinology and Metabolism 1995 80 2646-2652.
14. Juul A, Main K, Blum WF, Lindholm J, Ranke MB & Skakkebæk NE. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clinical Endocrinology 1994 41 85-93.
15. Cox GN, McDermott MJ, Merkel E, Stroh CA, Ko SC, Squires CH et al. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology 1994 135 1913-1920.
16. Rajkumar K, Barren D, Lewitt MS & Murphy LJ. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 1995 136 4029-4034.
17. Lewitt MS, Denyer GS, Cooney GJ & Baxter RC. Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology 1991 129 2254-2256.
18. Taylor AM, Dunger DB, Preece MA, Holly JM, Smith CP, Wass JA et al. The growth hormone-independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulindependent diabetics. Clinical Endocrinology 1990 32 229-239.
19. Baxter RC. Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Paediatrica Scandinavica (Suppl) 1991 372 107-114.
20. Wollmann HA, Schonau E, Blum WF, Meyer F, Kruse K & Ranke MB. Dose-dependent responses in insulin-like growth factors, insulin-like growth factor-binding protein-3 and parameters of bone metabolism to growth hormone therapy in young adults with growth hormone deficiency. Hormone Research 1995 43 249-256.
21. de Boer H, Blok GJ, Voerman B, de Vries P, Popp Snijders C & van der Veen E. The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis, Journal of Clinical Endocrinology and Metabolism 1995 80 2069-2076.
22. Shalet SM & Holmes SJ. Growth hormone replacement in adults. British Medical Journal 1994 308 1314-315.
23. de Boer H, Blok GJ, Popp Snijders C, Stuurman L, Baxter RC & van der Veen E. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. Journal of Clinical Endocrinology and Metabolism 1996 81 1371-1377.